First-in-human to Phase 4, and beyond
Real early-phase strength, with coverage across the whole development pathway.
01
Early-phase depth
First-in-human, Phase 0 and Phase 1 studies, including healthy volunteer trials, are where Avion CRO’s scientific leadership and the Australian speed advantage count most. Senior oversight of safety and tolerability, dose finding, early efficacy and faster time to first participant.
02
Coverage across every stage
From Phase 0 through to Phase 4, including registries and real-world data and real-world evidence databases, so the partnership does not end at approval.
03
Comfort with complexity
Adaptive and novel designs, not just standard protocols, with statisticians and scientists shaping the design from the start.
04
The Australian advantage, applied
The speed and cost benefits of running trials in Australia are strongest in the early phase. Read more.